KPV 5MG

£25.00

KPV (Lys–Pro–Val) is a tripeptide derived from the C-terminal fragment of α-melanocyte-stimulating hormone (α-MSH 11–13), used in experimental research to investigate melanocortin-related signalling and inflammation-associated cellular pathways.

  • Batch tested Purity: ≥ 99 % (HPLC, typical)
  • CAS Number: 67727-97-3
  • Peptide Type: Synthetic tripeptide (α-MSH(11–13) / ACTH(11–13) fragment)

Guaranteed Safe Checkout

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.

Reconstitution

Use bacteriostatic water. Add solvent slowly along vial wall. Do not shake gently swirl.

Cold Chain

Store lyophilised at 2–8°C. Once reconstituted, keep at 2–8°C and use within 28 days.

Certificate of Analysis

CoA available on request for each batch. HPLC and MS data provided.

  • Batch HPLC tested at 98.5%+ purity.
  • Store frozen long term or refrigerated when ready for use.
  • Sold for research purposes only.
  • Contact us for wholesale orders.

KPV

Synonyms / Designations: KPV, Lys–Pro–Val, α-MSH (11–13), α-Melanocyte-Stimulating Hormone fragment
CAS Number: 67727-97-3
Molecular Formula: C15H26N4O4
Molecular Weight: ~342.43 g/mol
Peptide Sequence: Lys–Pro–Val
Peptide Classification: Synthetic tripeptide; α-MSH-derived fragment
Purity: ≥99% (HPLC, typical)
Appearance: White to off-white lyophilised powder
Storage: Desiccated, protected from light, stored at –20 °C
Solubility: Soluble in sterile water and buffered aqueous solutions

Description & Mechanism

KPV is a synthetic tripeptide corresponding to amino acids 11–13 of α-melanocyte-stimulating hormone (α-MSH). It represents the minimal bioactive fragment commonly utilised in research settings to investigate melanocortin-associated signalling independently of the full-length peptide.

In biochemical and cellular research systems, KPV has been studied for its interactions with melanocortin-related pathways and downstream intracellular signalling mechanisms associated with immune modulation and inflammatory responses. Experimental studies typically examine receptor-independent and receptor-associated signalling effects, transcriptional responses, and peptide stability under controlled conditions. Observed molecular responses are dependent on experimental design, concentration, and model system, and are used to explore peptide-mediated signalling rather than defined biological or physiological outcomes.

Applications in Research

  • As a molecular probe for studying melanocortin-related signalling pathways.
  • Investigation of peptide-mediated modulation of inflammatory and immune-associated cellular responses.
  • In vitro studies examining short peptide signalling and stability.
  • Use as a reference compound in melanocortin and α-MSH fragment research.

Handling, Reconstitution & Stability

  • Weigh under dry conditions; peptide is hygroscopic.
  • Reconstitute in sterile water or an appropriate buffered aqueous solution depending on assay requirements.
  • Avoid vigorous agitation during dissolution.
  • Filter sterilise if required (e.g. 0.22 µm) immediately prior to use.
  • Aliquot and store reconstituted solutions at –20 °C (or lower).
  • Avoid repeated freeze–thaw cycles.

Precautions & Notes

  • Experimental behaviour of KPV is influenced by concentration, exposure duration, and experimental model.
  • Short peptide fragments may exhibit signalling profiles distinct from parent hormones.
  • Buffer composition, pH, and ionic strength may affect peptide stability and assay performance.
  • Appropriate controls are recommended to distinguish specific from non-specific effects.
  • Intended strictly for laboratory research use; not for human or veterinary application.

References

  1. Catania, A. et al. The neuroimmunomodulatory role of melanocortins. Endocrine Reviews, 2004.
    https://pubmed.ncbi.nlm.nih.gov/15082519/
  2. Lipton, J. M., Catania, A. Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunology Today, 1997.
    https://pubmed.ncbi.nlm.nih.gov/9368769/
  3. Brzoska, T. et al. α-MSH peptides and their receptors: biological functions. Journal of Endocrinology, 2008.
    https://pubmed.ncbi.nlm.nih.gov/18334621/
  4. Schiller, P. W. et al. Structure–activity relationships of melanocortin peptides and fragments. Annals of the New York Academy of Sciences.
    https://pubmed.ncbi.nlm.nih.gov/9463824/
  5. Getting, S. J. et al. The melanocortin peptide KPV inhibits inflammatory signalling pathways independently of classical melanocortin receptors. Journal of Immunology.
    https://pubmed.ncbi.nlm.nih.gov/12421969/
  6. Patel, H. B. et al. Anti-inflammatory effects of melanocortin peptides and minimal active fragments. British Journal of Pharmacology.
    https://pubmed.ncbi.nlm.nih.gov/16783407/
  7. PubChem. Lys–Pro–Val (KPV) peptide compound summary.
    https://pubchem.ncbi.nlm.nih.gov/compound/Lys-Pro-Val

Keywords: KPV, Lys–Pro–Val, α-MSH Fragment, Melanocortin Peptide, Synthetic Tripeptide, Peptide Signalling Research.